Mandy X Hu1, Brenda W J H Penninx2, Eco J C de Geus3, Femke Lamers2, Dora C-H Kuan4, Aidan G C Wright4, Anna L Marsland4, Matthew F Muldoon5, Stephen B Manuck4, Peter J Gianaros4. 1. Amsterdam Public Health Research Institute, Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: m.hu@ggzingeest.nl. 2. Amsterdam Public Health Research Institute, Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands. 3. Department of Biological Psychology, VU University, Amsterdam, The Netherlands. 4. Department of Psychology, University of Pittsburgh, PA, United States. 5. Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, PA, United States.
Abstract
OBJECTIVES: This study examined 1) the cross-sectional relationships between symptoms of depression/anxiety and immunometabolic risk factors, and 2) whether these relationships might be explained in part by cardiac vagal activity. METHODS: Data were drawn from the Adult Health and Behavior registries (n = 1785), comprised of community dwelling adults (52.8% women, aged 30-54). Depressive symptoms were measured with the Center for Epidemiological Studies Depression Scale (CES-D) and the Beck Depression Inventory-II (BDI-II), and anxious symptoms with the Trait Anxiety scale of the State-Trait Anxiety Inventory (STAI-T). Immunometabolic risk factors included fasting levels of triglycerides, high-density lipoproteins, glucose, and insulin, as well as blood pressure, waist circumference, body mass index, C-reactive protein, and interleukin-6. Measures of cardiac autonomic activity were high- and low-frequency indicators of heart rate variability (HRV), standard deviation of normal-to-normal R-R intervals, and the mean of absolute and successive differences in R-R intervals. RESULTS: Higher BDI-II scores, in contrast to CES-D and STAI-T scores, were associated with increased immunometabolic risk and decreased HRV, especially HRV likely reflecting cardiac vagal activity. Decreased HRV was also associated with increased immunometabolic risk. Structural equation models indicated that BDI-II scores may relate to immunometabolic risk via cardiac vagal activity (indirect effect: β = .012, p = .046) or to vagal activity via immunometabolic risk (indirect effect: β = -.015, p = .021). CONCLUSIONS: Depressive symptoms, as measured by the BDI-II, but not anxious symptoms, were related to elevated levels of immunometabolic risk factors and low cardiac vagal activity. The latter may exhibit bidirectional influences on one another in a meditational framework. Future longitudinal, intervention, an nonhuman animal work is needed to elucidate the precise and mechanistic pathways linking depressive symptoms to immune, metabolic, and autonomic parameters of physiology that predispose to cardiovascular disease risk.
OBJECTIVES: This study examined 1) the cross-sectional relationships between symptoms of depression/anxiety and immunometabolic risk factors, and 2) whether these relationships might be explained in part by cardiac vagal activity. METHODS: Data were drawn from the Adult Health and Behavior registries (n = 1785), comprised of community dwelling adults (52.8% women, aged 30-54). Depressive symptoms were measured with the Center for Epidemiological Studies Depression Scale (CES-D) and the Beck Depression Inventory-II (BDI-II), and anxious symptoms with the Trait Anxiety scale of the State-Trait Anxiety Inventory (STAI-T). Immunometabolic risk factors included fasting levels of triglycerides, high-density lipoproteins, glucose, and insulin, as well as blood pressure, waist circumference, body mass index, C-reactive protein, and interleukin-6. Measures of cardiac autonomic activity were high- and low-frequency indicators of heart rate variability (HRV), standard deviation of normal-to-normal R-R intervals, and the mean of absolute and successive differences in R-R intervals. RESULTS: Higher BDI-II scores, in contrast to CES-D and STAI-T scores, were associated with increased immunometabolic risk and decreased HRV, especially HRV likely reflecting cardiac vagal activity. Decreased HRV was also associated with increased immunometabolic risk. Structural equation models indicated that BDI-II scores may relate to immunometabolic risk via cardiac vagal activity (indirect effect: β = .012, p = .046) or to vagal activity via immunometabolic risk (indirect effect: β = -.015, p = .021). CONCLUSIONS:Depressive symptoms, as measured by the BDI-II, but not anxious symptoms, were related to elevated levels of immunometabolic risk factors and low cardiac vagal activity. The latter may exhibit bidirectional influences on one another in a meditational framework. Future longitudinal, intervention, an nonhuman animal work is needed to elucidate the precise and mechanistic pathways linking depressive symptoms to immune, metabolic, and autonomic parameters of physiology that predispose to cardiovascular disease risk.
Authors: Phyllis K Stein; Joshua I Barzilay; Paulo H M Chaves; Jennifer Traber; Peter P Domitrovich; Susan R Heckbert; John S Gottdiener Journal: J Am Geriatr Soc Date: 2008-01-04 Impact factor: 5.562
Authors: Anna L Marsland; Peter J Gianaros; Aric A Prather; J Richard Jennings; Serina A Neumann; Stephen B Manuck Journal: Psychosom Med Date: 2007-10-17 Impact factor: 4.312
Authors: Mandy X Hu; Femke Lamers; Sarah A Hiles; Brenda W J H Penninx; Eco J C de Geus Journal: Psychoneuroendocrinology Date: 2016-05-19 Impact factor: 4.905
Authors: Rita Haapakoski; Julia Mathieu; Klaus P Ebmeier; Harri Alenius; Mika Kivimäki Journal: Brain Behav Immun Date: 2015-06-09 Impact factor: 7.217
Authors: James A Dunbar; Prasuna Reddy; Nathalie Davis-Lameloise; Benjamin Philpot; Tiina Laatikainen; Annamari Kilkkinen; Stephen J Bunker; James D Best; Erkki Vartiainen; Sing Kai Lo; Edward D Janus Journal: Diabetes Care Date: 2008-10-03 Impact factor: 19.112
Authors: Mandy X Hu; Yuri Milaneschi; Femke Lamers; Ilja M Nolte; Harold Snieder; Conor V Dolan; Brenda W J H Penninx; Eco J C de Geus Journal: Depress Anxiety Date: 2019-10-17 Impact factor: 6.505